Abstract
Bone marrow transplantation has been established as a useful treatment for various hematological disorders and is now performed widely, but the mortality rate is still high due to various complications. A clear therapeutic policy for such complications has not yet been established because of their complex nature. We investigated whether the major complications occurring after bone marrow transplantation could be classified as aspects of the systemic inflammatory response syndrome. Subjects were 10 patients who developed severe complications after bone marrow transplantation (graft-versus-host disease, thrombotic microangiopathy, respiratory disorders, and cytomegalovirus interstitial pneumonitis) and 16 patients without complications. Their symptoms, serum cytokines, and factors related to vascular endothelial damage were compared before and after transplantation. Whereas all 10 patients who developed complications had fever in the aplastic phase after transplantation, 15 of the 16 patients without complications remained afebrile (P < 0.001, t-test). When compared with the patients who did not develop complications, the patients with complications also showed significantly higher cytokine levels during the recovery phase after transplantation (P < 0.0001, t-test). Thus, the patients with complications developed fever in the aplastic phase and showed an increase of cytokines during the recovery phase, which triggered the occurrence of vascular endothelial damage shown by factors such as the thrombomodulin and plasminogen activator inhibitor type 1. This sequence of events corresponds with that occurring during systemic inflammatory response syndrome, so many of the complications of bone marrow transplantation can be considered as manifestations of this syndrome. Bone Marrow Transplantation (2000) 26, 419–426.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Krenger W, Hill GR, Ferrara JML . Cytokine cascades in acute graft-versus-host disease Transplantation 1997 64: 553–558
Shulman HM, McDonald GB, Matthews D et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation Gastroenterology 1980 79: 1178–1191
Meyers JD, Flournoy N, Thomas ED . Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience Rev Infect Dis 1982 4: 1117–1132
Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 1994 14: 495–504
Enright H, Haake R, Weisdorf D et al. Cytomegalovirus pneumonia after bone marrow transplantation: risk factor and response to therapy Transplantation 1993 55: 1339–1346
Takatsuka H, Takemoto Y, Okamoto T et al. The levels of soluble P-selectin, von Willebrand factor and thrombomodulin in patients with neurological complications after allogeneic bone marrow transplantation Bone Marrow Transplant 1998 21: 809–813
Takatsuka H, Takemoto Y, Okamoto T et al. Adult respiratory distress syndrome-like disorders after allogeneic bone marrow transplantation Transplantation 1999 68: 1343–1347
Takatsuka H, Takemoto Y, Okamoto T et al. Thrombotic microangiopathy folloing allogeneic bone marrow transplantation Bone Marrow Transplant 1999 24: 303–306
Takatsuka H, Takemoto Y, Okamoto T et al. Predicting the severity of graft-versus-host disease from interleukin-10 after bone marrow transplantation Bone Marrow Transplant 1999 24: 1005–1007
Yamada S, Takatsuka H, Takemoto Y et al. Association of cytomegalovirus interstitial pneumonitis with HLA type following allogeneic bone marrow transplantation Bone Marrow Transplant 2000 25: 861–865
Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee . American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 1992 20: 864–874
Chen X, Christou NV . Relative contribution of endothelial cell and polymorphonuclear neutrophil activation in their interactions in systemic inflammatory response syndrome Arch Surg 1996 131: 1148–1154
Chao NJ, Schmidt GM, Niland JC et al. Cyclosporin, methotrexate and prednisone compared with cyclosporin and prednisone for prophylaxis of acute graft-versus-host disease New Engl J Med 1993 329: 1225–1230
Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigenemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation Br J Haematol 1994 186: 130–137
Singhal S, Mehta J, Powles R et al. Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 777–781
Zeigler ZR, Shadduck RK, Nemunaitis J et al. Bone marrow transplant-associated thrombotic microangiopathy: a caseseries Bone Marrow Transplant 1995 15: 247–253
Nunberger W, Michelmann I, Burdach S, Guel U . Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications Ann Hematol 1998 76: 61–65
Ogawa M . Mechanisms of the development of organ failure following surgical insult: the ‘second attack’ theory Clin Intens Care 1996 7: 34–38
Acknowledgements
We wish to thank Ms A Utsumi and Ms Y Shikita for their expert technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takatsuka, H., Takemoto, Y., Yamada, S. et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 26, 419–426 (2000). https://doi.org/10.1038/sj.bmt.1702517
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702517
Keywords
This article is cited by
-
Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management
Medical Oncology (2022)
-
Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis
Bone Marrow Transplantation (2021)
-
Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
American Journal of Clinical Dermatology (2019)
-
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
Bone Marrow Transplantation (2018)
-
The clinical value of biomarkers in respiratory complications in hematopoietic SCT
Bone Marrow Transplantation (2017)